Topic
Health Law
Posts
-
ArticleVol. 103 · Iss. 1
Drug Dealing: Making Public Pharma Work
The U.S. market for prescription drugs is failing many Americans. Drug prices in the United States are nearly three times higher than in comparable…
Sahil Agrawal, Melissa Barber, Amy Kapczynski & Trudel Pare -
ArticleVol. 102 · Iss. 3
A Constitutional False Claims Act
The False Claims Act (FCA) represents one of the most important sources, if not the most important source, of liability in the healthcare system…
Benjamin J. McMichael, Mackenzi Barrett & W. Kip Viscusi -
ArticleVol. 102 · Iss. 1
FDA Leads, States Must Follow
Courts have long deferred to the FDA’s scientific expertise, particularly on matters of drug safety and effectiveness. But now, in the aftermath of the…
Catherine M. Sharkey & Daniel J. Kenny -
ArticleVol. 101 · Iss. 3
The Ghosts of the Affordable Care Act
The Patient Protection and Affordable Care Act (ACA) is perhaps the most important piece of social legislation enacted in the United States in the…
Gabriel Scheffler -
ArticleVol. 99 · Iss. 4
New Innovation Models in Medical AI
ABSTRACT In recent years, scientists and researchers have devoted considerable resources to developing medical artificial intelligence (AI) technologies. Many of these technologies—particularly those that…
W. Nicholson Price II, Rachel E. Sachs & Rebecca S. Eisenberg -
NoteVol. 87 · Iss. 5
Supervision and Collaboration Requirements: The Vulnerability of Nurse Practitioners and Its Implications for Retail Health
Health care is expensive and scarce. These problems will only grow with the recent decline in the number of new physicians pursuing careers as…
Lauren E. Battaglia -
NoteVol. 88 · Iss. 5
How the Professional Judgment Standard Could Undermine the Validity of Sexually Violent Predator Laws
The Article presents common features of the statutory schemes for the involuntary dedication of sexually violent predators in the U.S. in 2011. It examines…
David W. Nordsieck -
Online2021
The Case for Banning Off-Label Use
New uses for drugs that are already on the market could help treat hundreds of diseases and thousands of people; however, the current system…
Christian Wolfgram -
NoteVol. 94 · Iss. 5
Wrongly “Identified”: Why an Actual Knowledge Standard Should Govern Health Care Providers’ False Claims Act Obligations to Report and Return Medicare and Medicaid Overpayments
In 2015, Medicare spent $632 billion on health care for America’s elderly (and other covered groups). Medicaid spent another $554 billion to provide health…
Nicholas J. Goldin -
NoteVol. 95 · Iss. 3
The Future of GMO Labeling: How a New Federal Labeling Scheme will Alter Public Disclosure
Genetic modification is a process used for a myriad of purposes, including the cultivation of plant species that ultimately find their way into countless…
Maria DeGiovanni -
ArticleVol. 95 · Iss. 1
Consumer Financial Protection in Health Care
There are inadequate consumer protections from harmful medical billing practices that result in unavoidable, unexpected, and often financially devastating medical bills. The problem stems…
Erin C. Fuse Brown -
ArticleVol. 96 · Iss. 6
The Consent Myth: Improving Choice for Patients of The Future
Consent has enjoyed a prominent position in the American privacy system since at least 1970, though historically, consent emerged from traditional notions of tort…
Charlotte A. Tschider